Changes in Treatment Patterns and Overall Survival for Early-Stage Diffuse Large B Cell Lymphoma in the United States After Rituximab: A Population-Based Analysis

被引：0
|
作者：
Haque, W. [1 ]
Tann, A. W. J. [2 ]
Szeja, S. [3 ]
Butler, E. B. [4 ]
Teh, B. S. [5 ]
机构：
[1] Greater Houston Phys Med Assoc, Houston, TX USA
[2] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] Houston Methodist Hosp, Weil Cornell Med Coll, Houston, TX USA
[5] Houston Methodist Hosp, Houston, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1007
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [21] Patient Survival with and Without Radiotherapy for Early Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab
    McLaughlin, C.
    Slade, A. N.
    Mukhopadhyay, N. D.
    Song, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S248 - S248
  • [22] Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma
    Wöhrer, S
    Püspök, A
    Drach, J
    Hejna, M
    Chott, A
    Raderer, M
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1086 - 1090
  • [23] RITUXIMAB IMPROVES QUALITIY OF RESPONSE AND SURVIVAL IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POPULATION-BASED STUDY
    Garcia-Sanchis, L.
    Teruel, A.
    Amat, P.
    Goterris, R.
    Ferrandez, A.
    Solano, C.
    Terol, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 : 227 - 228
  • [24] Primary diffuse large B-cell lymphoma of orbit: A population-based analysis
    Chen, Yu-Qing
    Yue, Zi-Fan
    Chen, Sai-Nan
    Tong, Fei
    Yang, Wei-Hua
    Wei, Rui-Li
    FRONTIERS IN MEDICINE, 2022, 9
  • [25] The Impact of Bulky Mass on Treatment Response and Overall Survival in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era
    Eren, Rafet
    Hakan, Muzaffer Ece
    Aslan, Ceyda
    Dogu, Mehmet Hilmi
    Altindal, Sermin
    Yokus, Osman
    Suyani, Elif
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2018, 28 (04): : 248 - 253
  • [26] Survival in Advanced Diffuse Large B-Cell Lymphoma in Pre- and Post-rituximab Eras in the United States
    Shah, Binay Kumar
    Bista, Amir
    Shafii, Bahman
    ANTICANCER RESEARCH, 2014, 34 (09) : 5117 - 5120
  • [27] Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era
    Wang, Xin
    Liu, Xin
    Zhong, Qiu-Zi
    Wu, Tao
    Wu, Yun-Peng
    Yang, Yong
    Chen, Bo
    Jing, Hao
    Tang, Yuan
    Jin, Jing
    Liu, Yue-Ping
    Song, Yong -Wen
    Fang, Hui
    Lu, Ning-Ning
    Li, Ning
    Zhai, Yi-Rui
    Zhang, Wen -Wen
    Wang, Shu-Lian
    Chen, Fan
    Qi, Shu-Nan
    Li, Ye-Xiong
    RADIOTHERAPY AND ONCOLOGY, 2023, 188
  • [28] Survival trends of primary testicular diffuse large B-cell lymphoma: A population-based study
    Mousa, M.
    Meshref, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study
    Szekely, Elisabeth
    Linden, Ola
    Peterson, Stefan
    Jerkeman, Mats
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (04) : 393 - 398
  • [30] Treatment patterns among elderly patients diagnosed with diffuse large B-cell lymphoma in the United States
    Simonella, Leonardo M.
    Thuresson, Per-Olof
    Surinach, Andy
    Napalkov, Pavel
    Corvino, Frank A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 282 - 283
12345